PLUS1
4.37
0.02 (0.46%)
0.02 (0.46%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 21,881 |
|
|||||
| News | - | ||||||
| Day High | 4.522 | Low High |
|||||
| Day Low | 4.30 | ||||||
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Anixa Biosciences Inc | ANIX | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| 0.02 | 0.46% | 4.37 | 11:45:50 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.35 | 4.30 | 4.522 | 4.37 | 4.35 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 214 | 21,881 | US$ 4.39 | US$ 96,069 | - | 2.30 - 6.2491 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 08:00:13 | 3 | US$ 4.37 | USD |
Period:
Draw Mode:
Anixa Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 131.77M | 30.15M | 28.70M | US$ 512.50k | US$ - | -0.44 | -7.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | 1.34M | 16.60% |
Anixa Biosciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 28/1/2023 | 08:06 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) |
| 05/1/2023 | 09:01 | Edgar (US Regulatory) | Annual Report (10-k) |
| 20/12/2022 | 00:30 | PR Newswire (US) | Anixa Biosciences to Present at Biotech Showcase 2023 |
| 09/12/2022 | 22:15 | TipRanks | H.C. Wainwright Sticks to Their Buy Rating for Anixa.. |
| 09/12/2022 | 00:41 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 09/12/2022 | 00:30 | PR Newswire (US) | Anixa Biosciences Announces Maximum Tolerated Dose Reached.. |
| 09/11/2022 | 00:30 | PR Newswire (US) | Anixa Biosciences Announces Presentation on Breast Cancer.. |
| 31/10/2022 | 23:30 | PR Newswire (US) | Dr. Jose Conejo-Garcia, Invited to Present Keynote Address.. |
| 26/10/2022 | 23:30 | PR Newswire (US) | Anixa Biosciences Announces Commencement of Phase 1b Trial.. |
| 10/10/2022 | 23:30 | PR Newswire (US) | Anixa Biosciences Announces Presentation on Ovarian Cancer.. |
| 29/9/2022 | 22:31 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 20/9/2022 | 20:03 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
Historical ANIX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.55 | 4.68 | 4.23 | 4.44 | 33,892 | -0.18 | -3.96% |
| 1 Month | 4.22 | 5.04 | 4.0201 | 4.49 | 41,310 | 0.15 | 3.55% |
| 3 Months | 5.24 | 5.56 | 3.50 | 4.51 | 45,166 | -0.87 | -16.6% |
| 6 Months | 3.72 | 6.2491 | 3.50 | 4.88 | 70,574 | 0.65 | 17.47% |
| 1 Year | 3.06 | 6.2491 | 2.30 | 4.00 | 73,634 | 1.31 | 42.81% |
| 3 Years | 3.61 | 8.09 | 1.33 | 3.69 | 243,251 | 0.76 | 21.05% |
| 5 Years | 4.48 | 8.09 | 1.33 | 3.77 | 191,933 | -0.11 | -2.46% |